Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousGranulocyte Colony-Stimulating FactorGranulocytesTransplantation ConditioningPeripheral Blood Stem Cell TransplantationBone Marrow TransplantationStem CellsLiver TransplantationHematopoietic Stem CellsGraft vs Host DiseaseHematopoietic Stem Cell MobilizationKidney TransplantationMultiple MyelomaGraft SurvivalHematologic NeoplasmsTreatment OutcomeReceptors, Granulocyte Colony-Stimulating FactorCell TransplantationMelphalanCombined Modality TherapyTransplantation ChimeraTissue DonorsRecurrenceNeutropeniaWhole-Body IrradiationHeart TransplantationMesenchymal Stem Cell TransplantationCord Blood Stem Cell TransplantationBone Marrow CellsHematopoiesisBusulfanRemission InductionAntigens, CD34Myeloablative AgonistsLung TransplantationBone MarrowRetrospective StudiesSalvage TherapyCell DifferentiationCyclophosphamideLymphoma, Non-HodgkinImmunosuppressive AgentsAntineoplastic Combined Chemotherapy ProtocolsVision, EntopticDisease-Free SurvivalSurvival AnalysisTime FactorsLeukocyte CountColony-Forming Units AssayHistocompatibility TestingRecombinant ProteinsSurvival RateEmbryonic Stem CellsOrgan TransplantationTransplantation ImmunologyCells, CulturedGraft RejectionCarmustineColony-Stimulating FactorsBone Marrow PurgingLeukemiaLeukapheresisHistocompatibilityAdult Stem CellsGraft vs Tumor EffectEtoposideHodgkin DiseaseFollow-Up StudiesIslets of Langerhans TransplantationTransplantationLeukemia, Myeloid, AcuteCytarabineTransplantation, IsogeneicPancreas TransplantationMyelodysplastic SyndromesGraft vs Leukemia EffectGranulocyte-Macrophage Colony-Stimulating FactorPrognosisVidarabinePluripotent Stem CellsImmunosuppressionNeutrophilsLiving DonorsCell SeparationHLA AntigensMesenchymal Stromal CellsNeural Stem CellsNeoplasm, ResidualHepatic Veno-Occlusive DiseaseVincristineStem Cell NicheChimerismHematologic DiseasesLymphocyte TransfusionLymphomaBlood Component RemovalFlow Cytometry